AquaBounty Technologies, Inc.

Informe acción NasdaqCM:AQB

Capitalización de mercado: US$5.1m

AquaBounty Technologies Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de AquaBounty Technologies han disminuido a una tasa media anual de -19.3%, mientras que en la industria Biotechs los beneficios crecieron en un 33.8% anualmente. Los ingresos han ido disminuyendo a una tasa media de 39.4% al año.

Información clave

-19.30%

Tasa de crecimiento de los beneficios

-13.88%

Tasa de crecimiento del BPA

Crecimiento de la industria Biotechs 17.04%
Tasa de crecimiento de los ingresos-39.40%
Rentabilidad financieran/a
Margen neton/a
Última actualización de beneficios31 Mar 2026

Actualizaciones de resultados anteriores recientes

Recent updates

Seeking Alpha • Aug 20

AquaBounty: Not Casting A Lure Yet

This land-based salmon producer is a unique take on aquaculture, but risks abound. The current market cap does not take into consideration the low production plans, even with a new facility under construction. The looming clouds on the horizon means I will dock my boat for until things clear. A Pass On Land Based Fish Farms AquaBounty (AQB) is a company developing dry land farms to raise and sell salmon to the market to take demand away from wild caught salmon. The hot words to consider is that these salmon are both genetically engineered and farm raised. Public image issues aside, other risks that have plagued the company are due to the lack of FDA approval (of farm sites) and harvest issues. This has prevented this aging company from seeing any significant development since the early 90s. AquaBounty August Investor Presentation Advantages of the AquaBounty platform, or the trademark AquAdvantage Salmon, are many-fold. Initially, the major benefits revolve around faster growth, reproduction cycles, and ease of harvest, all allowing for a reduction in salmon cost. This either allows AquaBounty to sell at market price for a significant profit, or attempt to steal major market share by offering the lowest prices. Residual effects revolve around the issues inherent in wild-caught fish: ecological impacts, transportation impact, catch risks, food-borne illness, or biomagnification. The current issue is that AquaBounty is still working out the kinks and is yet to produce a full-scale operational facility. However, the bet is that once equilibrium is found, the platform, or these farms and salmon, can be developed worldwide, and the market share looks to be significant. In particular, it seems that commercial usage looks quite favorably upon the genetically engineered salmon, and in time, retail consumers may swing around as well. Investors should feel quite confident in the ability to find customers, but uncertainty around the funding of aquaculture centers and the improvement of harvest yields will be an issue for the coming years. Just look at the small amount of revenues that have been found since initiating the process nearly 30 years ago. Koyfin Revenues are derived from two initial farms in Indiana and Prince Edward Island, Canada. However, these sites will only have a maximum yield of approximately 1,000 metric tons per year. This contrasts significantly with the over 160 million tons of salmon processed per year, in the US. The table below is a great way to realize the sheer size of the fishery market, and to begin understanding the benefits of taking a dent out of the amount of fish we obtain from the oceans. Because of this, AquaBounty’s story will remain not one plagued by demand issues, but rather supply constraints. To combat the lack of supply from their two initial production experiment sites, the company has recently begun construction of a larger 10,000 metric ton facility that will easily provide over 5x current harvest yields. NOAA Fisheries 2020 Report The main problem, as usual, is money. While the company has done well to raise millions at the peak of the recent bull market, current estimates for the price of the new facility will drain the coffer. Now the company is not looking to dilute but to issue bonds instead, partially tempering the hit to current shareholders. However, no funding has come for six quarters and the cash on hand is slowly falling away. As of the August earnings press release, management had the following comments: On the bond financing front, we have decided to slow the process down temporarily in order to evaluate the current economic forces that are driving both inflation and interest rates higher. Since our estimate for construction of the farm currently exceeds our previous range of $290 - $320 million, we will review all options for reducing cost, including potentially phasing the construction of the 10,000 metric ton farm with an initial production output level that would demonstrate our competitive advantage and ability to operate at commercial scale. Koyfin AquaBounty The Future As only uncertainty exists and current supply is only worth a few million per year, I will certainly be remaining on the sideline. However, I look to the success of their construction and will be following their developments. If you are interested in this story, I will offer some valuation points to consider. Based on prices provided by the 2020 NOAA Fisheries report (see above), the value per pound for Salmon is approximately $5/lb at commercial scale.
Seeking Alpha • Aug 09

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies press release (NASDAQ:AQB): Q2 GAAP EPS of -$0.08. Revenue of $1.07M (+365.2% Y/Y).
Seeking Alpha • Mar 15

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

AquaBounty is an aquaculture company that bioengineered an FDA-approved genetically modified fish (AquAdvantage salmon) that grows faster and requires less food. CEO Sylvia Wulf on challenging GMO misinformation. AquaBounty’s financials and what investors can expect moving forward in terms of capital raises and shareholder dilution.
Artículo de análisis • May 09

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Artículo de análisis • Feb 10

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Every investor in AquaBounty Technologies, Inc. ( NASDAQ:AQB ) should be aware of the most powerful shareholder groups...
Artículo de análisis • Dec 20

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Even if it's not a huge purchase, we think it was good to see that Richard Huber, the Independent Non-Executive...

Desglose de ingresos y gastos

Cómo gana y gasta dinero AquaBounty Technologies. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqCM:AQB Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 260-430
31 Dec 250-240
30 Sep 250-8270
30 Jun 250-8370
31 Mar 250-11080
31 Dec 240-1190
30 Sep 24-2-31110
30 Jun 24-1-34120
31 Mar 240-10120
31 Dec 230-14131
30 Sep 232-25121
30 Jun 232-25121
31 Mar 233-24121
31 Dec 223-22111
30 Sep 223-22111
30 Jun 223-24112
31 Mar 222-23112
31 Dec 211-22102
30 Sep 211-22102
30 Jun 210-1992
31 Mar 210-1782
31 Dec 200-1672
30 Sep 200-1472
30 Jun 200-1372
31 Mar 200-1482
31 Dec 190-1372
30 Sep 190-1443
30 Jun 190-1453
31 Mar 190-1343
31 Dec 180-1243
30 Sep 180-1174
30 Jun 180-1074
31 Mar 180-1064
31 Dec 170-953
30 Sep 170-963
30 Jun 170-953
31 Mar 170-953
31 Dec 160-853
30 Sep 160-844
30 Jun 160-734
31 Mar 160-744
31 Dec 150-743
30 Sep 150-743

Ingresos de calidad: AQB actualmente no es rentable.

Margen de beneficios creciente: AQB actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: AQB no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 19.3% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de AQB en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: AQB no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Biotechs (43%).

Rentabilidad financiera

Alta ROE: El pasivo de AQB supera su activo, por lo que es difícil calcular su rentabilidad financiera.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/25 05:31
Precio de las acciones al final del día2026/05/22 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

AquaBounty Technologies, Inc. está cubierta por 3 analistas. 0 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Frank BarlowKeefe, Bruyette, & Woods
Benjamin KlieveLake Street Capital Markets, LLC
Colin RuschOppenheimer & Co. Inc.